Pay in 4 interest-free payments of $6.19 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Adding once-daily lixisenatide for type 2 diabetes inadequately controlled with newly initiated and continuously titrated basal insulin glargine: a 24-week, randomized, placebo-controlled study (GetGoal-Duo 1)
Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol
Current Pharmaceutical Design (2018) This comparative study examines BPC-157's angiogenic properties alongside standard growth factors including VEGF (Vascular Endothelial Growth Factor) and bFGF (basic Fibroblast Growth Factor) in established wound healing models
By continuing, you confirm that you are of legal age and are purchasing these products strictly for laboratory research purposes only
US$ 20.70
US$ 24.16
US$ 21.77
US$ 25.66
US$ 25.70
US$ 26.97
US$ 21.47
US$ 20.89
US$ 24.58
US$ 23.68
